Latest Information Update: 22 Feb 2016
Price : $50
At a glance
- Originator Almirall S.A.
- Mechanism of Action Phosphatidylinositol 3 kinase delta inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Asthma; Chronic obstructive pulmonary disease
Most Recent Events
- 01 Sep 2014 Preclinical trials in Chronic obstructive pulmonary disease in Spain (Inhalation)
- 01 Sep 2014 Preclinical trials in Asthma in Spain (Inhalation)